NCT03323801View on ClinicalTrials.gov

RA-4: 13-cis Retinoic Acid for Treatment of Men With Azoospermia

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 25, 2017

Primary Completion Date

May 16, 2019

Study Completion Date

May 31, 2019

Conditions
Male Infertility, Azoospermia
Interventions
DRUG

13-cis retinoic acid

Accutane is used for the treatment of severe acne

Trial Locations (1)

98195

University of Washington Medical Center, Seattle

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of Washington

OTHER

NCT03323801 - RA-4: 13-cis Retinoic Acid for Treatment of Men With Azoospermia | Biotech Hunter | Biotech Hunter